Paromomycin sulfate
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), PATH, Fundacion Nacional de Dermatologia
Conditions
CryptosporidiosisHIV InfectionsLeishmania Braziliensis ComplexLeishmaniasis, AmericanLeishmaniasis, CutaneousLeishmaniasis; American, CutaneousVisceral Leishmaniasis
Phase 2
A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3
CompletedNCT00000771
End: 1996-09-30Target: 68Updated: 2021-11-04
Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia
CompletedNCT03096457
Start: 2017-04-15End: 2018-04-01Updated: 2021-02-02
Phase 3
Phase 4
Unknown Phase
Treatment of Chronic Cryptosporidiosis in AIDS Patients
TerminatedNCT00001128
End: 2005-06-30Target: 16Updated: 2016-12-14
An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
CompletedNCT01328457
Start: 2011-01-31End: 2012-06-30Updated: 2014-04-04